Naomi Murai

Chemoprevention of intestinal polyposis in the APCDelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor

Jilly F. Evans, Masanobu Oshima, Naomi Murai et al. · The American Journal of Gastroenterology · 2000 · 336 citations

Medicine, Genetics, Oncology +17

Role of the Y1 Receptor in the Regulation of Neuropeptide Y-Mediated Feeding: Comparison of Wild-Type, Y1 Receptor-Deficient, and Y5 Receptor-Deficient Mice

Satoshi Mashiko, Naomi Murai, Nami Sugimoto et al. · Endocrinology · 2000 · 241 citations · Full text

Life Sciences, Neuroscience, Physiology +17

Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.

Naomoto Harada, Hiroyuki Miyoshi, Naomi Murai et al. · PubMed · 2002 · 166 citations

Medicine, Molecular Biology, Oncology +17

A Typical Y1 Receptor Regulates Feeding Behaviors: Effects of a Potent and Selective Y1 Antagonist, J-115814

Akio Kanatani, M. Hata, Satoshi Mashiko et al. · Molecular Pharmacology · 2001 · 98 citations

Medicine, Neuroscience, Pharmacology +17

A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice

Akane Ishihara, Akio Kanatani, Satoshi Mashiko et al. · Proceedings of the National Academy of Sciences · 2006 · 76 citations · Full text

Medicine, Endocrinology, Pharmacology +17